stoney delivers again...
BLI BERKELEY LTS INC COM
$21.57+3.01 (+16.22%)
Taking the $3 trade may be back later today....
BLI BERKELEY LTS INC COM
$21.57+3.01 (+16.22%)
Taking the $3 trade may be back later today....
GBA Presents: THE GREEN MARKET
- Thread starter stonedinvestor
- Start date
OCT 18th Special Apple Event.....
The Do)
500 OCULAR THERAPEUTIX INC COM (OCUL) Planted in the garden @ $11.78
CATALYST DRIVEN IDEA: Morgan Stanley analyst Ravi Shanker told investors in a research note that he expects "imminent news" from TuSimple on two potential catalysts, namely the company's "Driver Out" test and an update on the CFIUS inquiry regarding the 2017 investment into TuSimple from Sina as part of its Series B fund raising. Shanker expects a final resolution for both these catalysts within the next three months or "potentially as soon as in the next few days/weeks." The analyst named the stock as a catalyst driven idea given the view that a positive resolution, or even updates, on either or both could potentially drive as much as about 50% upside.
WELL THE TIME HAS FINALLY COME---- VAN.
Shanker has identified the "Driver Out" test as a key milestone for TuSimple on the "path to demonstrating the commercial viability of autonomous driving not just for the company, but perhaps for the industry." This test will involve running a Class 8 truck on public highways with regular traffic for an extended period, without a human inside the truck. The analyst noted that management seemed "extremely confident and in very good spirits" regarding this catalyst during his recent field trip and demo run. Shanker has an Overweight rating and $75 price target on TuSimple shares.
500 OCULAR THERAPEUTIX INC COM (OCUL) Planted in the garden @ $11.78
CATALYST DRIVEN IDEA: Morgan Stanley analyst Ravi Shanker told investors in a research note that he expects "imminent news" from TuSimple on two potential catalysts, namely the company's "Driver Out" test and an update on the CFIUS inquiry regarding the 2017 investment into TuSimple from Sina as part of its Series B fund raising. Shanker expects a final resolution for both these catalysts within the next three months or "potentially as soon as in the next few days/weeks." The analyst named the stock as a catalyst driven idea given the view that a positive resolution, or even updates, on either or both could potentially drive as much as about 50% upside.
WELL THE TIME HAS FINALLY COME---- VAN.
Shanker has identified the "Driver Out" test as a key milestone for TuSimple on the "path to demonstrating the commercial viability of autonomous driving not just for the company, but perhaps for the industry." This test will involve running a Class 8 truck on public highways with regular traffic for an extended period, without a human inside the truck. The analyst noted that management seemed "extremely confident and in very good spirits" regarding this catalyst during his recent field trip and demo run. Shanker has an Overweight rating and $75 price target on TuSimple shares.
R U Wit' ME-! TuSimple Boy!
Berkley was good.R U Wit' ME-! TuSimple Boy!
No opinion on OCUL today.
I would not buy TSP. Wait for below $30.
Don't lose your uranium plays. All up nicely today and it's contract signing season for nuke plants buying uranium. There is plenty of upside left to be had.
for unknowable reasons i've been obsessed with calling the bottom on Gamida GMDA. I have attempted to buy the bottom several times, and each time we get a fresh, stunningly low bottom. could this one be it? one day this thing is going to recover. it's got some sort of pipeline update planned for 8am Oct 26.
Gamida Cell Ltd
NASDAQ: GMDA
4.14 USD +0.30 (7.68%)today
Oct 12, 2:56 PM EDT
Gamida Cell Ltd
NASDAQ: GMDA
4.14 USD +0.30 (7.68%)today
Oct 12, 2:56 PM EDT
Berkeley Lights still 'meaningfully oversold,' says BTIG 14:16 BLI BTIG analyst Mark Massaro notes Berkeley Lights delivered a "solid" pre-announced Q3 beat, which appears to be sending at least one short investor to the exits, as the stock is up 14% on the news. The analyst "applauds management's decision to pre-announce," reinforcing the fact that Berkeley Lights continues to sign new customers and is also executing on its newer subscription offering. Following the pre-announcement and after speaking with management, Massaro continues to believe that shares of Berkeley Lights are "meaningfully oversold" even with Tuesday's bounce, as shares are down 80% from its peak in December despite solid operational execution. The analyst has a Buy rating and a price target of $65 on the shares.